Dihydro CP Syrup and Pasireotide Extended-Release Injection
Determining the interaction of Dihydro CP Syrup and Pasireotide Extended-Release Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: chlorpheniramine / dihydrocodeine / pseudoephedrine
Brand name:
Synonyms: n.a.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydro CP Syrup-Pasireotide Injection
- Dihydro CP Syrup-Pasireotide Subcutaneous
- Dihydro CP Syrup-Patanase
- Dihydro CP Syrup-Patiromer
- Dihydro CP Syrup-Patiromer Sorbitex Calcium
- Dihydro CP Syrup-Pavacot
- Pasireotide Extended-Release Injection-Dihydrocodeine BPM Phenyleph HCl
- Pasireotide Extended-Release Injection-Dihydrocodeine, Aspirin, and Caffeine
- Pasireotide Extended-Release Injection-Dihydroergotamine
- Pasireotide Extended-Release Injection-Dihydroergotamine injection
- Pasireotide Extended-Release Injection-Dihydroergotamine Mesylate
- Pasireotide Extended-Release Injection-Dihydroergotamine nasal